Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

Males and females ≥ 18 and ≤ 85 years of age

Patients must have histologically confirmed diagnosis of WHO grade IV glioblastoma (including variants such as gliosarcoma, giant cell glioblastoma).

Single, gadolinium-enhancing tumor recurrence ≤ 3cm in maximum diameter

Patient not amenable for surgical resection due to any of the following but not limited reasons: patient refusal, medically ineligible, surgically too high risk due to tumor location in a deep and/or eloquent location.